1. Home
  2. GBIO vs PPSI Comparison

GBIO vs PPSI Comparison

Compare GBIO & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • PPSI
  • Stock Information
  • Founded
  • GBIO 2016
  • PPSI 2008
  • Country
  • GBIO United States
  • PPSI United States
  • Employees
  • GBIO N/A
  • PPSI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • PPSI Electrical Products
  • Sector
  • GBIO Health Care
  • PPSI Industrials
  • Exchange
  • GBIO Nasdaq
  • PPSI Nasdaq
  • Market Cap
  • GBIO 29.2M
  • PPSI 30.0M
  • IPO Year
  • GBIO 2020
  • PPSI N/A
  • Fundamental
  • Price
  • GBIO $0.33
  • PPSI $2.67
  • Analyst Decision
  • GBIO Strong Buy
  • PPSI Strong Buy
  • Analyst Count
  • GBIO 4
  • PPSI 1
  • Target Price
  • GBIO $7.33
  • PPSI $12.00
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • PPSI 37.5K
  • Earning Date
  • GBIO 08-06-2025
  • PPSI 05-15-2025
  • Dividend Yield
  • GBIO N/A
  • PPSI 56.18%
  • EPS Growth
  • GBIO N/A
  • PPSI N/A
  • EPS
  • GBIO N/A
  • PPSI 2.84
  • Revenue
  • GBIO $24,556,000.00
  • PPSI $26,304,000.00
  • Revenue This Year
  • GBIO N/A
  • PPSI $24.01
  • Revenue Next Year
  • GBIO N/A
  • PPSI $19.25
  • P/E Ratio
  • GBIO N/A
  • PPSI $0.94
  • Revenue Growth
  • GBIO 146.47
  • PPSI 439.46
  • 52 Week Low
  • GBIO $0.30
  • PPSI $2.25
  • 52 Week High
  • GBIO $3.65
  • PPSI $7.00
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 42.78
  • PPSI 46.95
  • Support Level
  • GBIO $0.31
  • PPSI $2.64
  • Resistance Level
  • GBIO $0.36
  • PPSI $2.78
  • Average True Range (ATR)
  • GBIO 0.03
  • PPSI 0.10
  • MACD
  • GBIO -0.00
  • PPSI 0.00
  • Stochastic Oscillator
  • GBIO 27.27
  • PPSI 46.15

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

Share on Social Networks: